In this setting, the PACAP/PAC1 axis could serve as a regulatory pathway to prevent aberrant ER stress or UPR activation, a pathway that could potentially find application as a target for the treatment of neurodegenerative disorders that exhibit overt signs of sustained ER stress, including the most severe forms of progressive MS [12]. This evidence concerns the gene ADCYAP1R1 and myeloid sarcoma.